Screener
Ginkgo Bioworks DNA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's restricted cash?
- Ginkgo Bioworks (DNA) reported restricted cash of $2.92M in Q2 2026.
- How has Ginkgo Bioworks's restricted cash changed year-over-year?
- Ginkgo Bioworks's restricted cash decreased by 73.4% year-over-year, from $10.95M to $2.92M.
- What is the long-term trend for Ginkgo Bioworks's restricted cash?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's restricted cash has grown at a 54.8% compound annual growth rate (CAGR), from $5.08M to $45.17M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Ginkgo Bioworks's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude